Clinical Trial Update: Cetuximab for Elderly Patients With mCRC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab in elderly patients with metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED